The team is under guidance of Tsugiya FUKUI and the objectives are to quantitatively assessing the risk of iPS cell-derived differentiated cells after transplantation
Nikkei Biotech news release, November 20, 2015
The team is under guidance of Tsugiya FUKUI and the objectives are to quantitatively assessing the risk of iPS cell-derived differentiated cells after transplantation
Nikkei Biotech news release, November 20, 2015